Patents
Patents for C07D 271 - Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms (7,144)
07/2007
07/04/2007CN1993363A 1,3-disubstituted heteroaryl nmda/nr2b antagonists
07/04/2007CN1990457A 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands
07/04/2007CN1324018C Oligopeptides and compositions containing them as cathepsin S inhibitors
07/04/2007CN1324006C Beta-amino acid nitrile derivs.
07/04/2007CN1324001C Novel thyroid receptor ligands
06/2007
06/28/2007WO2007071742A1 Improved process for the preparation of 4-(benzimidazolylmethylamino)-benzamides and the salts thereof
06/28/2007WO2007071609A1 Malononitrile compounds
06/28/2007WO2007035430A3 Process for the preparation of benzo [e] [1,2,4] triazepin-2-one derivatives
06/28/2007US20070149589 Process for the Preparation of 4-(benzimidazolylmethylamino)benzamidines
06/28/2007US20070149516 to treat cellular proliferative diseases, hyperplasias, solid tumor, cardiac hypertrophy, immune disorders and inflammation; modulators of one or more mitotic kinesins; N-(2-(2-dimethylamino-acetylamino)-1-{4-[8-(1-hydroxy-ethyl)-imidazo[1,2-a]pyridin-2-yl]-benzyl}-ethyl)-3-chloro-4-isopropoxy-benzamide
06/28/2007DE102005061427A1 Substituierte Oxadiazol-Derivate Substituted oxadiazole derivatives
06/28/2007CA2634601A1 Malononitrile compounds
06/28/2007CA2631832A1 Improved process for the preparation of 4-(benzimidazolylmethylamino)-benzamides and the salts thereof
06/27/2007EP1799659A1 Compounds for nonsense suppression, and methods for their use
06/27/2007EP1799217A1 Compounds and methods of treating insulin resistance and cardiomyopathy
06/26/2007US7235664 Potassium channel modulators; antiarrhythmia agents
06/21/2007WO2007069773A1 A pharmaceutical composition comprising an amide derivative
06/21/2007US20070142381 Calcium receptor modulating agents
06/21/2007US20070142333 Cycloalkyl inhibitors of potassium channel function
06/21/2007US20070142229 Agriculture
06/20/2007EP1797094A2 1,3-disubstituted heteroaryl nmda/nr2b antagonists
06/20/2007EP1381590B1 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands
06/14/2007WO2007067994A1 Inhibitors of histone deacetylase for the treatment of disease
06/14/2007WO2007067993A1 Inhibitors of histone deacetylase for the treatment of disease
06/14/2007WO2007067817A1 Abca1 elevating compounds
06/14/2007WO2007065821A1 Propionamide compounds as antiinflammatory agents
06/14/2007US20070135500 Propionamide compounds as antiinflammatory agents
06/14/2007US20070135485 Novel mch receptor antagonists
06/14/2007DE102005027589B3 Temperatur-/Bestrahlungs-/Polymerisationsindikatoren Temperature / radiation / Polymerisationsindikatoren
06/14/2007CA2632531A1 Propionamide compounds as antiinflammatory agents
06/13/2007EP1416931B1 Inhibitors of polyq-aggregation
06/13/2007CN1980892A Dpp-IV inhibitors
06/12/2007US7230031 Thyroid hormone receptor ligand, medicinal compositions containing the same and use thereof
06/12/2007US7229988 for the treatment and/or prevention of medical dysfunctions and diseases such as stroke, Parkinson's disease, and Alzheimer's disease caused by reactive oxygen species and/or excess Zn ions; neuroprotectants
06/12/2007US7229987 Oxazoles with one or more tertiary amine groups and phenyl groups, e.g., 1-{4-[2-(Benzofuran-2-ylmethoxymethyl)-oxazol-5-yl]-phenyl}-3-(2-dimethylamino-ethyl)-urea and -(3-{4-[2-(2-Phenoxy-ethylsulfanylmethyl)-oxazol-5-yl]-phenoxy}-propyl)-azepine; treating obesity and related diseases, e.g., diabetes
06/12/2007CA2354023C Phenylglycine derivatives
06/07/2007WO2007062773A1 Oxadiazole derivatives with crth2 receptor activity
06/07/2007US20070129354 Biphenyl carboxylic amide p38 kinase inhibitors
06/07/2007US20070129349 Alpha, beta -peptide inhibitors; Alzheimer's disease; 2-(4-Chloro-benzenesulfonylamino)-3-phenyl-propionic acid methyl ester
06/07/2007CA2631652A1 Oxadiazole derivatives with crth2 receptor activity
06/06/2007EP1558669A4 Electroluminescent metallo-supramolecules with terpyridine-based groups
06/05/2007US7226921 An enzyme inhibitor of cysteine proteases, a morpholine-4-carboxyamide 1,3,4-oxadiazole derivatives; for treating arthritis, muscular dystrophy, inflammation, tumor, glomerulonephritis, malaria, periodontal disease
05/2007
05/31/2007WO2007060112A1 Salicylic acid derivatives
05/31/2007CA2630805A1 Salicylic acid derivatives
05/30/2007EP1789410A1 Methylene dipiperidine derivatives
05/30/2007EP1789381A2 Inhibitors of histone deacetylase
05/30/2007EP1003730B1 2-benzoyl-cyclohexane-1,3-diones
05/30/2007EP0914605B1 Molecular model for vla-4 inhibitors
05/30/2007CN1972919A Method for producing 4-(benzimidazolylmethylamino)-benzamidines
05/29/2007US7223791 Function regulator for retinoid relative receptor
05/23/2007EP1786768A1 Arylsulphonylstilbene derivatives for treatment of insomnia and related conditions
05/23/2007EP1254895B1 Nitrogenous cyclic compounds and pharmaceutical compositions containing the same
05/23/2007EP1212619B1 Substrates and screening methods for transport proteins
05/23/2007CN1966503A 2,6-dimethyl-3,5-bi-(2-methyl-3-N-acetyl-5-phenyl-[1,3,4] oxadiazoles) pyridine and its synthesis method
05/22/2007US7220745 Viricides; therapy for hepatitis virus infections
05/22/2007US7220734 1-(amino)indanes and (1,2-dihydro-3-amino)-benzofurans, benzothiophenes and indoles as Edg receptor agonists
05/18/2007WO2007056469A2 Certain chemical entities, compositions, and methods
05/17/2007US20070112046 2'-Methyl-5'-(1,3,4-Oxadiazol-2-yl)-1,1'-Biphenyl-4-Carboxamide Derivatives and Their Use As P38 Kinase Inhibitors
05/17/2007US20070112045 Triazole ppar modulators
05/17/2007US20070112002 1-[2-(4,4-dimethylcyclohexyl)-5-methoxyphenyl]-4-pentylpiperazine; excellent cell adhesion inhibitory action or cell infiltration inhibitory action; inflammatory diseases and autoimmune diseases such as ulcerative colitis, Crohn's disease, irritable bowel syndrome, rheumatoid arthritis, psoriasis, asthma
05/17/2007US20070111999 P-38 kinase inhibitors
05/17/2007US20070107835 Ethynyl containing electron transport dyes and compositions
05/15/2007US7217832 5-amidino-2-hydroxybenzenesulfonamide derivatives, pharmaceutical compositions containing the same and intermediates for their preparation
05/15/2007US7217740 Diarylsulfones as 5-HT2A antagonists
05/10/2007US20070105899 Benzene compounds
05/10/2007US20070105892 Amidino compounds as cysteine protease inhibitors
05/09/2007EP1781286A2 Mitotic kinesin inhibitors
05/09/2007CN1960978A Amine compound and organic electroluminescent element employing the same
05/09/2007CN1314393C Method for treating hair-dropping using thyromimetic compound
05/08/2007US7214694 Controlling transforming growth facor; artificial skin; wound healing agents
05/08/2007CA2275479C Prevention of loss and restoration of bone mass by certain prostaglandin agonists
05/03/2007WO2007048771A1 Arylurea derivatives as modulators of chemokine receptor activity
05/03/2007CA2626324A1 Arylurea derivatives as modulators of chemokine receptor activity
05/02/2007EP1778682A1 Heterocyclic compounds useful as dpp- iv inhibitors
05/02/2007EP1658285B1 Compounds, methods and formulations for the oral delivery of a glucagon like peptide (glp)-1 compound or an melanocortin 4 receptor (mc4) agonist peptide
05/01/2007USRE39607 Herbicidal sulphonylamino(thio) carbonyl compounds
05/01/2007US7211680 (5Z,7E,22E)-(1S,3R,24R)-25-phenyl-26,27-cyclo-9,10-secocholesta-5,7,10(19),22-tetraene-1,3,24-triol; treating hyperprolifierative diseases of the skin, tumor diseases and precancerous stages, auto-immune diseases, rejection reactions in the case of autologous, allogenic or xenogenic transplants, AIDS
05/01/2007US7211668 PNA monomer and precursor
05/01/2007CA2305458C Nonsteroidal (hetero) cyclically-substituted acylanilides with mixed gestagenic and androgenic activity
04/2007
04/26/2007WO2007045366A1 Heterocyclic compounds with carboxyl isostere groups and their use for the treatment of cardiovascular diseases
04/26/2007WO2006133216A3 4-substituted arylamine derivatives and their use in pharmaceutical compositions
04/26/2007WO2006120133A3 Process for coloring keratin fibers comprising metal complexes
04/26/2007US20070093487 Novel polycyclic compounds which modulate PPARgamma type receptors and cosmetic/pharmaceutical compositions comprised thereof
04/26/2007DE102005050497A1 Difluorphenol-Derivate und ihre Verwendung Difluorophenol derivatives and their use
04/26/2007DE102005050377A1 Heterocyclische Verbindungen und ihre Verwendung Heterocyclic compounds and their use
04/26/2007CA2626449A1 Heterocyclic compounds and their use
04/25/2007CN1951947A Organometallic complex, and light-emitting element and light-emitting device using the same
04/24/2007US7208509 Non-nucleoside reverse transcriptase inhibitors
04/24/2007CA2171934C Endothelin receptor antagonists
04/19/2007WO2007043401A1 Nitrogenated heterocyclic compound and pharmaceutical composition comprising the same
04/19/2007WO2007043400A1 Nitrogenated aromatic heterocyclic compound and pharmaceutical composition comprising the same
04/19/2007CA2623327A1 Nitrogenated heterocyclic compound and pharmaceutical composition comprising the same
04/18/2007EP1773398A2 Novel sulfonamides as inhibitors of histone deacetylase for the treatment of disease
04/18/2007EP1476438B1 Oxa- and thiadiazoles and their use as metalloproteinase inhibitors
04/18/2007EP1353662B1 Methods for the treatment of diseases using malonyl-coa decarbox ylase inhibitors
04/18/2007CN1950349A 1,2,4-oxadiazole derivatives as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes
04/18/2007CN1948309A Organic eurepium compound based on functional o-phenan throline ligand and its electroluminous device
04/18/2007CN1948294A Amino acid diphenyl compound
04/17/2007US7205321 preventing, treating diabetes mellitus, Syndrome X, cardiovascular disease , hyperglycemia, hyperlipidemia, obesity, coagaulopathy, hypertension, atherosclerosis in a mammal
04/12/2007US20070082897 Acylated indanyl amines and their use as pharmaceuticals
1 ... 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 ... 72